Terms: = Breast cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864
286 results:
1. RAD52-dependent mitotic DNA synthesis is required for genome stability in Cyclin E1-overexpressing cells.
Audrey A; Kok YP; Yu S; de Haan L; van de Kooij B; van den Tempel N; Chen M; de Boer HR; van der Vegt B; van Vugt MATM
Cell Rep; 2024 Apr; 43(4):114116. PubMed ID: 38625790
[TBL] [Abstract] [Full Text] [Related]
2. [Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
Sang D; Fan SM; Li SY; Zhang JT; Wang HM; Zhao XH; Zheng LJ; Liang P; Xi GB; Zhao LM; Zhang YR; Yuan P
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):256-262. PubMed ID: 38494772
[No Abstract] [Full Text] [Related]
3. Thoracic aorta injury detected by 4D flow MRI predicts subsequent main adverse cardiovascular events in breast cancer patients receiving anthracyclines: A longitudinal study.
Shen H; Zhou W; ChunrongTu ; Peng Y; Li X; Liu D; Wang X; Zhang X; Zeng X; Zhang J
Magn Reson Imaging; 2024 Jun; 109():67-73. PubMed ID: 38484947
[TBL] [Abstract] [Full Text] [Related]
4. Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Gerosa R; De Sanctis R; Jacobs F; Benvenuti C; Gaudio M; Saltalamacchia G; Torrisi R; Masci G; Miggiano C; Agustoni F; Pedrazzoli P; Santoro A; Zambelli A
Crit Rev Oncol Hematol; 2024 Apr; 196():104324. PubMed ID: 38462150
[TBL] [Abstract] [Full Text] [Related]
5. Validation of artificial intelligence contrast mammography in diagnosis of breast cancer: Relationship to histopathological results.
Helal M; Khaled R; Alfarghaly O; Mokhtar O; Elkorany A; Fahmy A; El Kassas H
Eur J Radiol; 2024 Apr; 173():111392. PubMed ID: 38428255
[TBL] [Abstract] [Full Text] [Related]
6. A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315.
Watts LP; Spencer SL
Cancer Discov; 2024 Mar; 14(3):386-388. PubMed ID: 38426558
[TBL] [Abstract] [Full Text] [Related]
7. In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK.
Pham DD; Pham TH; Bui TH; Britikova EV; Britikov VV; Bocharov EV; Usanov SA; Phan VC; Le TBT
Mol Biol Rep; 2024 Jan; 51(1):130. PubMed ID: 38236367
[TBL] [Abstract] [Full Text] [Related]
8. Drain-free mastectomy and flap fixation: The interim analysis of a randomized controlled noninferiority trial.
Spiekerman van Weezelenburg MA; de Rooij L; Aldenhoven L; van Kuijk SMJ; van Haaren ERM; Janssen A; Vissers YLJ; Beets GL; van Bastelaar J
J Surg Oncol; 2024 Apr; 129(5):975-980. PubMed ID: 38173366
[TBL] [Abstract] [Full Text] [Related]
9. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of cancer.
Wang Y; Wang C; Liu T; Qi H; Chen S; Cai X; Zhang M; Aliper A; Ren F; Ding X; Zhavoronkov A
J Med Chem; 2024 Jan; 67(1):420-432. PubMed ID: 38146659
[TBL] [Abstract] [Full Text] [Related]
11. Anti-breast cancer activity of biosynthesized selenium nanoparticles using Bacillus coagulans supernatant.
Khaledizade E; Tafvizi F; Jafari P
J Trace Elem Med Biol; 2024 Mar; 82():127357. PubMed ID: 38103517
[TBL] [Abstract] [Full Text] [Related]
12. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
13. INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors.
Dietrich C; Trub A; Ahn A; Taylor M; Ambani K; Chan KT; Lu KH; Mahendra CA; Blyth C; Coulson R; Ramm S; Watt AC; Matsa SK; Bisi J; Strum J; Roberts P; Goel S
Cancer Discov; 2024 Mar; 14(3):446-467. PubMed ID: 38047585
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Mechanism Analysis of Protopine Against Triple Negative breast cancer.
Chen T; Jiang H; Hu G; Acma FM; Huang B
Stud Health Technol Inform; 2023 Nov; 308():480-486. PubMed ID: 38007774
[TBL] [Abstract] [Full Text] [Related]
15. Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health-related quality of life and supportive care needs.
Maras AF; Penedo FJ; Ramirez AG; Worch SM; Ortiz MS; Yanez B; Munoz E; Lad T; Hollowell C; Medina HN; Moreno PI
Support Care Cancer; 2023 Nov; 31(12):711. PubMed ID: 37982906
[TBL] [Abstract] [Full Text] [Related]
16. Using Radiomics to Differentiate Brain Metastases From Lung cancer Versus breast cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract] [Full Text] [Related]
17. Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis.
Xu H; Wang X; Xu X; Liu L; Zhang Y; Yan X; Zhang Y; Dang K; Li Y
Clin Nutr; 2023 Dec; 42(12):2493-2502. PubMed ID: 37922693
[TBL] [Abstract] [Full Text] [Related]
18. breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study.
Jarm K; Zadnik V; Birk M; Vrhovec M; Hertl K; Klanecek Z; Studen A; Sval C; Krajc M
Radiol Oncol; 2023 Sep; 57(3):337-347. PubMed ID: 37665745
[TBL] [Abstract] [Full Text] [Related]
19. Empower the Potential of Trastuzumab Deruxtecan with Novel Combinations.
Rolfo C; Del Re M; Russo A
Clin Cancer Res; 2023 Nov; 29(21):4317-4319. PubMed ID: 37656059
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
Tsoi H; Lok J; Man EP; Cheng CN; Leung MH; You CP; Chan SY; Chan WL; Khoo US
J Pathol; 2023 Oct; 261(2):156-168. PubMed ID: 37555303
[TBL] [Abstract] [Full Text] [Related]
[Next]
